Performance

RIGL +19.49%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
RIGL	+6.05%	-1.82%	+19.49%	+5.40%	-50.08%	0.54	0.00%

Summary

RIGL at a glance

RIGL returned +19.49% over the past year and +5.40% a year over five years. Its worst drop in that year was -50.08%, smaller than 23% of stocks on Redstone, and its Sharpe ratio of 0.54 beats 52% of stocks on Redstone. It pays no dividends.

Ranking

How RIGL ranks

Current Drawdown

-18.27%

Rolling Volatility

70.56%

Actions

Metrics

Risk Indicators

Alpha19.91%

Beta0.99x

Sharpe0.54

Sortino0.76

Omega1.10

Calmar0.39

Martin1.05

Profile

About RIGL

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $785M
Listed: Nov 2000
Employees: 174
Headquarters: South San Francisco, CA
Website: rigel.com

Comparisons

RIGL: Rigel Pharmaceuticals, Inc.

RIGL at a glance

How RIGL ranks

Current Drawdown

Rolling Volatility

About RIGL

Related comparisons